NantHealth, Inc. (NASDAQ:NH) has a beta value of 1.92 and has seen 4,070,877 shares traded in the last trading session. The company, currently valued at $475.67 Million, closed the last trade at $4.3 per share which meant it lost -$0.2 on the day or -5.29% during that session. The NH stock price is -24.88% off its 52-week high price of $5.37 and 89.53% above the 52-week low of $0.45. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.55 Million shares traded. The 3-month trading volume is 555.32 Million shares.
The consensus among analysts is that NantHealth, Inc. (NH) is a Buy stock at the moment, with a recommendation rating of 0. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 2 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.05.
NantHealth, Inc. (NASDAQ:NH) trade information
Despite being -5.29% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Jun 24 when the NH stock price touched $5.37-1 or saw a rise of 19.93%. Year-to-date, NantHealth, Inc. shares have moved 317.48%, while the 5-day performance has seen it change 22.86%. Over the past 30 days, the shares of NantHealth, Inc. (NASDAQ:NH) have changed 66.02%. Short interest in the company has seen 266.33 Million shares shorted with days to cover at 0.48.
Wall Street analysts have a consensus price target for the stock at $3.3, which means that the shares’ value could jump -23.26% from current levels. The projected low price target is $3.1 while the price target rests at a high of $3.5. In that case, then, we find that the current price level is -18.6% off the targeted high while a plunge would see the stock lose -27.91% from current levels.
NantHealth, Inc. (NH) estimates and forecasts
Figures show that NantHealth, Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +309.52% over the past 6 months, with this year growth rate of -8%, compared to 1% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -25% and 14.3% for the next quarter. Revenue growth from the last financial year stood is estimated to be -22.6%.
2 analysts offering their estimates for the company have set an average revenue estimate of $18.08 Million for the current quarter. 2 have an estimated revenue figure of $18.81 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $25.69 Million and $22.36 Million respectively for this quarter and the next, and analysts expect sales will grow by -29.6% for the current quarter and -15.9% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +4.1% over the past 5 years. Earnings growth for 2020 is a modest +67.5% while over the next 5 years, the company’s earnings are expected to increase by 0%.
NantHealth, Inc. (NASDAQ:NH)’s Major holders
Insiders own 64.34% of the company shares, while shares held by institutions stand at 18.63% with a share float percentage of 52.24%. Investors are also buoyed by the number of investors in a company, with NantHealth, Inc. having a total of 32 institutions that hold shares in the company. The top two institutional holders are DG Capital Management, LLC with over 13.82 Million shares worth more than $21.97 Million. As of March 30, 2020, DG Capital Management, LLC held 12.49% of shares outstanding.
The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 1.31 Million shares as of March 30, 2020. The firm’s total holdings are worth over $2.08 Million and represent 1.18% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of March 30, 2020, the former fund manager holds about 0.8% shares in the company for having 883276 shares of worth $1.4 Million while later fund manager owns 374.39 Thousand shares of worth $595.27 Thousand as of March 30, 2020, which makes it owner of about 0.34% of company’s outstanding stock.